Impact of bedaquiline regimen on the treatment success rates of multidrug-resistant tuberculosis patients in Egypt

Impact of bedaquiline regimen on the treatment success rates of multidrug-resistant tuberculosis patients in Egypt

Abstract Bedaquiline (BDQ), an innovative anti-tuberculous (TB) agent, has attracted attention for its potential effectiveness against drug-resistant TB. This study investigated the impact of BDQ-containing regimens on treatment success rates among multi-drug resistant tuberculosis (MDR-TB) patients...

Full description

Bibliographic Details
Main Authors: Magda Afifi, Wagdy Amin, Dina Helal, Rasha Ashmawy, Yousra A. El-Maradny, Noha Khalifa, Ramy Mohamed Ghazy
Format: Article
Language:English
Published: Nature Portfolio 2024-07-01
Series:Scientific Reports
Subjects:
Tuberculosis
Infectious diseases
MDR-TB
Antibiotic resistance
Bedaquiline
Egypt
Online Access:https://doi.org/10.1038/s41598-024-65063-8

Internet

https://doi.org/10.1038/s41598-024-65063-8

Similar Items